Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vascular endothelial growth factor family and receptor expression in human choroidal neovascular membranes.

× No keyword cloud information.

36 in total

1. The pharmacology study of a new recombinant human VEGF receptor-fc fusion protein on experimental choroidal neovascularization.

Authors: Ming Zhang; Dechao Yu; Chun Yang; Qingjie Xia; Wang Li; Bin Liu; Hong Li
Journal: Pharm Res Date: 2008-10-15 Impact factor: 4.200

2. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration.

Authors: Imran A Bhutto; D Scott McLeod; Takuya Hasegawa; Sahng Y Kim; Carol Merges; Patrick Tong; Gerard A Lutty
Journal: Exp Eye Res Date: 2005-07-12 Impact factor: 3.467

3. Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.

Authors: Matthias Bolz; Stephan Michels; Wolfgang Geitzenauer; Franz Prager; Ursula Schmidt-Erfurth
Journal: Br J Ophthalmol Date: 2006-10-18 Impact factor: 4.638

4. Intravitreal tanibirumab, a fully human monoclonal antibody against vascular endothelial growth factor receptor 2, partially suppresses and regresses laser-induced choroidal neovascularization in a rat model.

Authors: Jaeryung Kim; Tae Eun Kim; Ju-A Kim; Ji-Hyun Yun; Seongsoo Sohn; Sang Ryeol Shim; Sang Hoon Lee; Sang Jin Kim
Journal: J Ocul Pharmacol Ther Date: 2014-12 Impact factor: 2.671

Review 5. Role of growth factors and the wound healing response in age-related macular degeneration.

Authors: Reinier O Schlingemann
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2003-12-18 Impact factor: 3.117

Review 6. Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications.

Authors: Claudio Campa; Ciro Costagliola; Carlo Incorvaia; Carl Sheridan; Francesco Semeraro; Katia De Nadai; Adolfo Sebastiani; Francesco Parmeggiani
Journal: Mediators Inflamm Date: 2010-08-25 Impact factor: 4.711

Vascular endothelial growth factor family and receptor expression in human choroidal neovascular membranes.

1. The pharmacology study of a new recombinant human VEGF receptor-fc fusion protein on experimental choroidal neovascularization.

2. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration.

3. Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.

4. Intravitreal tanibirumab, a fully human monoclonal antibody against vascular endothelial growth factor receptor 2, partially suppresses and regresses laser-induced choroidal neovascularization in a rat model.

Review 5. Role of growth factors and the wound healing response in age-related macular degeneration.

Review 6. Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications.

7. Intravitreal ranibizumab (Lucentis) for the treatment of myopic choroidal neovascularization.

8. An anti-angiogenic reverse thermal gel as a drug-delivery system for age-related wet macular degeneration.

9. [The role of Stratus OCT in anti-VEGF therapy. Qualitative and quantitative assessment of neovascular AMD].

10. Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP).